Orcinol

Orcinol

SCHEMBL236740

Cc1cc(O)cc(O)c1.O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Orcinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 4/20 0.48
CHRM1 known ✓ P11229 1/20 0.43
ADRA1A known ✓ P35348 1/20 0.43
HTR2B known ✓ P41595 1/20 0.43
MEN1 known ✓ O00255 1/20 0.38
ESR1 known ✓ P03372 1/20 0.38
THRB known ✓ P10828 1/20 0.38
ESR2 known ✓ Q92731 1/20 0.38
HDAC6 known ✓ Q9UBN7 1/20 0.38
ALDH1A1 P00352 5/20 0.80
BACE1 P56817 1/20 0.57
HCAR1 Q9BXC0 1/20 0.52
SELL P14151 1/20 0.47
SELP P16109 1/20 0.47
SELE P16581 1/20 0.47
CYP3A4 P08684 3/20 0.43
ALOX15 P16050 2/20 0.43
MAOA P21397 2/20 0.43
TBXA2R P21731 1/20 0.43
HSD17B1 P14061 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orcinol SCHEMBL68497 0.96
Orcinol SCHEMBL11786364 0.93 ALDH1A1 (0.80) ALDH1A1BACE1HCAR1ACHESELL
Orcinol SCHEMBL7894743 0.93
Orcinol SCHEMBL11445808 0.93 ALDH1A1 (0.80) ALDH1A1BACE1HCAR1ACHESELL
Orcinol SCHEMBL7591999 0.93 ALDH1A1 (0.80) ALDH1A1BACE1HCAR1ACHESELL
Orcinol SCHEMBL1886757 0.90 ALDH1A1 (0.75) ALDH1A1BACE1HCAR1ACHESELL
Orcinol SCHEMBL1886756 0.90 ALDH1A1 (0.75) ALDH1A1BACE1HCAR1ACHESELL
SCHEMBL11574035 0.89 ALDH1A1 (1.00) ALDH1A1BACE1HCAR1ACHESELL
SCHEMBL28714 0.89
Phloroglucinol SCHEMBL28465719 0.89 ALDH1A1 (0.86) ALDH1A1BACE1HCAR1ACHESELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112710645-B Method for detecting dopamine and alkaline phosphatase in real time through permanganate-initiated in-situ fluorescence reaction and enzyme-linked immunosorbent assay (ELISA) application thereof 南京工业大学 2022-09-30 CN claimed
CN-112710645-A Method for detecting dopamine and alkaline phosphatase in real time through permanganate-initiated in-situ fluorescence reaction and enzyme-linked immunosorbent assay (ELISA) application thereof 南京工业大学 2021-04-27 CN claimed
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2020-07-02 US claimed
EP-1300487-B1 Copper plating bath ROHM & HAAS ELECT MAT (US) 2017-10-04 EP claimed
US-20130298933-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2013-11-14 US claimed
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL S.A. (FR) 2010-12-02 US claimed
US-20050155866-A1 Plating bath and method for depositing a metal layer on a substrate SHIPLEY COMPANY, L.L.C. (US) 2005-07-21 US claimed
US-6773573-B2 ELECTROLYTIC CELLS; BATH MIXTURE CONTAINING ALCOHOLS; STABILITY SHIPLEY COMPANY, L.L.C. 2004-08-10 US claimed
US-20030102226-A1 Plating bath and method for depositing a metal layer on a substrate SHIPLEY COMPANY, L.L.C. 2003-06-05 US claimed
EP-1300487-A1 Plating bath and method for depositing a metal layer on a substrate Shipley Co. L.L.C. (US) 2003-04-09 EP claimed
US-6497895-B2 TRANSDERMAL PATCH RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-12-24 US claimed
US-6365146-B1 POLYAMIDEESTER COPOLYMER RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-04-02 US claimed
US-6328988-B1 DRUGS AND COSMETICS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-12-11 US claimed
EP-0494925-A4 POLYMERIZABLE (FUNCTIONALLY-SUBSTITUTED PHENYLENE) SEMI-RIGID CROWNS 1993-01-20 EP claimed
US-5142068-A MONO- AND DI(FUNCTIONALLY-SUBSTITUTED PHENYLENE) SEMI-RIGID CROWNS AND PROCESSES FOR MAKING VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1992-08-25 US claimed
EP-0494925-A1 POLYMERIZABLE (FUNCTIONALLY-SUBSTITUTED PHENYLENE) SEMI-RIGID CROWNS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1992-07-22 EP claimed
WO-1991004971-A1 POLYMERIZABLE (FUNCTIONALLY-SUBSTITUTED PHENYLENE) SEMI-RIGID CROWNS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1991-04-18 WO claimed
EP-4713436-A1 ENZYME-CONVERTED RED BLOOD CELLS FOR INCREASED COMPATIBILITY OF ABO-UNIVERSAL BLOOD TRANSFUSION Danmarks Tekniske Universitet (DK) 2026-03-25 EP disclosed
EP-0003295-A1 Phenoxy-phenoxy-alkylcarboxylic acid derivatives with herbicidal activity, their preparation, compositions containing them and their use CIBA-GEIGY AG (CH) 1979-08-08 EP disclosed
US-4163112-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1979-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B ACHE 4025/4885CHRM1 4636/4885ADRA1A 2957/4885
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B ACHE 4025/4885CHRM1 4636/4885ADRA1A 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.